[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369158-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369158-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pan-cancer-analysis-of-kank2-clinical-and-molecular-insights-into-tumor-progression-and-therapeutic-implications","Pan-Cancer Analysis of KANK2 - Clinical and Molecular Insights into Tumor Progression and Therapeutic Implications","","KANK2 is investigated as a gene important for cell migration and movement and its links to cancer biology. The study evaluates KANK2 expression across 33 cancers using TCGA and GTEx, integrating diagnostic and prognostic analyses. ROC, Kaplan-Meier, and Cox regression assess clinical relevance, while subtype, mutation, and DNA methylation associations are explored. Functional correlations, GSEA pathways, PPI networks, drug-sensitivity findings, and WB/qPCR validation support the conclusion that KANK2 may serve as a diagnostic and prognostic biomarker and potential therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pan-cancer-analysis-of-kank2-clinical-and-molecular-insights-into-tumor-progression-and-therapeutic-implications/369158/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-of-kank2-clinical-and-molecular-insights-into-tumor-progression-and-therapeutic-implications/369158.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of the study on KANK2?","Question",{"text":63,"@type":64},"To analyze KANK2 expression across 33 cancer types and determine its diagnostic and prognostic significance, including its molecular and clinical implications.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which datasets and databases are used to assess KANK2?",{"text":68,"@type":64},"The study uses TCGA and GTEx for expression analysis and incorporates tools/databases such as TISIDB, cBioPortal, GEO, STRING, HPA, UALCAN, and related platforms for subtype, genetic alteration, and pathway analyses.",{"name":70,"@type":61,"acceptedAnswer":71},"How is KANK2 verified experimentally in the study?",{"text":72,"@type":64},"Results are validated using two GEO datasets and experimental assays including western blot (WB) and qPCR, with cell experiments in KIRC cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369158,1791217104,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Ivyspring  \nInternational Publisher  \nJournal of Cancer  \n2025; 16(4): 1149-1166. doi: 10.7150/jca.105098  \nResearch Paper  \nPan-Cancer Analysis of KANK2: Clinical and Molecular Insights into Tumor Progression and Therapeutic Implications  \nKai Zhao1, Jie Lin1, Yongzhi Li1, Shenghao Xu2, Fei Wang3􀀍, Yongsheng Yang1􀀍  \n1. Department of Hepatobiliary and Pancreatic Surgery, Changchun, Jilin Province, China.  \n2. Department of Orthopedics, The Second Hospital of Jilin University, Changchun, Jilin Province, China.  \n3. Department of Endocrinology, Weifang People's Hospital, Weifang, Shandong Province, China.  \n􀀍 Corresponding authors: Prof. Yongsheng Yang, Department of Hepatobiliary and Pancreatic Surgery, The Second Hospital of Jilin University, Ziqiang St No.  \n218, Changchun, 130041 Jilin Province, [China. Email: ysyang@jlu.edu.cn.](China. Email: ysyang@jlu.edu.cn. Dr. Fei Wang)[ Dr. Fei Wang](China. Email: ysyang@jlu.edu.cn. Dr. Fei Wang), Department of Endocrinology, Weifang People's Hospital, Guangwen Street No.151, Kuiwen District, Weifang, 261000 Shandong Province, China. E-mail: [fayekfbbx@163.com](fayekfbbx@163.com).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2024.10.12; Accepted: 2024.12.24; Published: 2025.01.06  \nAbstract  \nBackground: KANK2, a gene crucial for cell migration and movement, is implicated in neoplastic and non-neoplastic diseases. This study aimed to analyze KANK2's expression and its diagnostic and prognostic significance across 33 cancers using multiple online databases.  \nMethods: This study aimed to comprehensively analyze KANK2 in 33 cancers using The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) database. Multiple web platforms and software were used for data analysis, including R, Cytoscape, HPA, TISIDB, UALCAN, GEO, cBioPortal, STRING, GSCALite, and CancerSEA. WB and qPCR experiments were used to verify the results. Results: KANK2 is widely expressed in various tissues and has significant diagnostic value in multiple cancers, with AUC values exceeding 0.75 in 13 cancer types. Survival analysis indicated that KANK2 expression is significantly associated with overall survival (OS) and disease-specific survival (DSS) in several cancers. KANK2 expression varied significantly across different molecular and immune subtypes and was associated with specific genetic mutations and DNA methylation patterns. Functional state analysis highlighted correlations with processes such as EMT, angiogenesis, and apoptosis. GSEA identified pathways related to proliferation, migration, and extracellular matrix remodeling. The key interacting proteins were identified by PPI network analysis, and the sensitive drug molecules were found by GSCA database. The results were also confirmed by two GEO datasets and WB and qPCR results. Conclusion: KANK2 serves as a valuable biomarker for diagnosis and prognosis in various cancers, and its expression is intricately linked to multiple molecular and cellular processes, offering potential therapeutic targets for future research.  \nKeywords: KANK2; Pan-Cancer Analysis; Tumor Immunity; Bioinformatics; Experimental Verification  \nIntroduction  \nCancer remains a significant global health challenge, highlighting the urgent need for enhanced understanding of its molecular mechanisms[1] . Within this framework, the KANK family, recognized for its roles in cytoskeletal dynamics and cellular signaling, has emerged as a potential contributor to cancer progression[2-4] with KANK2 being particularly influential[5, 6] . However, a thorough  \nevaluation of KANK2's expression and function across various cancer types is still missing. The inconsistency in KANK2 expression levels across different tumor","cbCairpxjbPliuyV","https://ap.wps.com/l/cbCairpxjbPliuyV","pdf",11949976,18,"English","# Abstract\n# Introduction\n# Materials and Methods","[{\"question\":\"What is the main purpose of the study on KANK2?\",\"answer\":\"To analyze KANK2 expression across 33 cancer types and determine its diagnostic and prognostic significance, including its molecular and clinical implications.\"},{\"question\":\"Which datasets and databases are used to assess KANK2?\",\"answer\":\"The study uses TCGA and GTEx for expression analysis and incorporates tools/databases such as TISIDB, cBioPortal, GEO, STRING, HPA, UALCAN, and related platforms for subtype, genetic alteration, and pathway analyses.\"},{\"question\":\"How is KANK2 verified experimentally in the study?\",\"answer\":\"Results are validated using two GEO datasets and experimental assays including western blot (WB) and qPCR, with cell experiments in KIRC cells.\"}]","Pan-Cancer Analysis of KANK2 - Clinical and Molecular Insights into Tumor Progression and Therapeutic Implications | PDF",1790181086,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53c34e22e6bd2e6a00cf9368e34bce4d.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7a69bc7a3ef3d69bf0630918ce67fba.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f58f2c14f1c559c85df3ff8aaa6a3f6.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a03f26e53514b1fd008814b9f16ed20d.webp",980,1268]